when to stop taking glp 1 Pause or a GLP-1: A Decision Framework Weaning off a GLP-1? Tips

15 Two large, randomized control trials (RCTs) investigating liraglutide and semaglutide also suggested worsening retinopathy as an adverse effect of GLP-1RA use

One 12-week randomized clinical trial found that subjects receiving 1mg daily lost an average of 2.6kg compared to 0.8kg in the placebo group

Although most current studies are confounded by metabolic comorbidities, recent findings by Nicolau et al 5 begin to address this gap by evaluating the effects of GLP-1 RAs in metabolically healthy patients, providing preliminary support for a direct immunologic mechanism

The modifications are reversible and are achieved with the aid of related enzymes

This process involves the nuclear localization signal, allowing NRF2 to traverse the nuclear pore and enter the cell nucleus